Literature DB >> 23104667

Identification of tissue-specific targeting peptide.

Eunkyoung Jung1, Nam Kyung Lee, Sang-Kee Kang, Seung-Hoon Choi, Daejin Kim, Kisoo Park, Kihang Choi, Yun-Jaie Choi, Dong Hyun Jung.   

Abstract

Using phage display technique, we identified tissue-targeting peptide sets that recognize specific tissues (bone-marrow dendritic cell, kidney, liver, lung, spleen and visceral adipose tissue). In order to rapidly evaluate tissue-specific targeting peptides, we performed machine learning studies for predicting the tissue-specific targeting activity of peptides on the basis of peptide sequence information using four machine learning models and isolated the groups of peptides capable of mediating selective targeting to specific tissues. As a representative liver-specific targeting sequence, the peptide "DKNLQLH" was selected by the sequence similarity analysis. This peptide has a high degree of homology with protein ligands which can interact with corresponding membrane counterparts. We anticipate that our models will be applicable to the prediction of tissue-specific targeting peptides which can recognize the endothelial markers of target tissues.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23104667     DOI: 10.1007/s10822-012-9614-6

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  49 in total

Review 1.  Transcytosis: crossing cellular barriers.

Authors:  Pamela L Tuma; Ann L Hubbard
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

2.  Machine learning study for the prediction of transdermal peptide.

Authors:  Eunkyoung Jung; Seung-Hoon Choi; Nam Kyung Lee; Sang-Kee Kang; Yun-Jaie Choi; Jae-Min Shin; Kihang Choi; Dong Hyun Jung
Journal:  J Comput Aided Mol Des       Date:  2011-03-30       Impact factor: 3.686

3.  Alpha v integrins as receptors for tumor targeting by circulating ligands.

Authors:  R Pasqualini; E Koivunen; E Ruoslahti
Journal:  Nat Biotechnol       Date:  1997-06       Impact factor: 54.908

4.  Membrane dipeptidase is the receptor for a lung-targeting peptide identified by in vivo phage display.

Authors:  D Rajotte; E Ruoslahti
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

Review 5.  Cochlin and glaucoma: a mini-review.

Authors:  Sanjoy K Bhattacharya; Neal S Peachey; John W Crabb
Journal:  Vis Neurosci       Date:  2005 Sep-Oct       Impact factor: 3.241

6.  A new set of amino acid descriptors and its application in peptide QSARs.

Authors:  Hu Mei; Zhi H Liao; Yuan Zhou; Shengshi Z Li
Journal:  Biopolymers       Date:  2005       Impact factor: 2.505

7.  Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells.

Authors:  Flavio Curnis; Gianluigi Arrigoni; Angelina Sacchi; Lucia Fischetti; Wadih Arap; Renata Pasqualini; Angelo Corti
Journal:  Cancer Res       Date:  2002-02-01       Impact factor: 12.701

8.  Screening and identification of a peptide specifically targeted to NCI-H1299 from a phage display peptide library.

Authors:  Linquan Zang; Lei Shi; Jiao Guo; Qin Pan; Wei Wu; Xuediao Pan; Junye Wang
Journal:  Cancer Lett       Date:  2009-03-26       Impact factor: 8.679

9.  Artificial neural network models for prediction of intestinal permeability of oligopeptides.

Authors:  Eunkyoung Jung; Junhyoung Kim; Minkyoung Kim; Dong Hyun Jung; Hokyoung Rhee; Jae-Min Shin; Kihang Choi; Sang-Kee Kang; Min-Kook Kim; Cheol-Heui Yun; Yun-Jaie Choi; Seung-Hoon Choi
Journal:  BMC Bioinformatics       Date:  2007-07-11       Impact factor: 3.169

Review 10.  Aptamers for Targeted Drug Delivery.

Authors:  Partha Ray; Rebekah R White
Journal:  Pharmaceuticals (Basel)       Date:  2010-05-27
View more
  9 in total

1.  Development of a peptide by phage display for SPECT imaging of resistance-susceptible breast cancer.

Authors:  Benjamin M Larimer; Susan L Deutscher
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-08-15

2.  Circumsporozoite Protein of Plasmodium berghei- and George Baker Virus A-Derived Peptides Trigger Efficient Cell Internalization of Bioconjugates and Functionalized Poly(ethylene glycol)-b-poly(benzyl malate)-Based Nanoparticles in Human Hepatoma Cells.

Authors:  Elise Vène; Kathleen Jarnouen; Catherine Ribault; Manuel Vlach; Yann Verres; Mickaël Bourgeois; Nicolas Lepareur; Sandrine Cammas-Marion; Pascal Loyer
Journal:  Pharmaceutics       Date:  2022-04-06       Impact factor: 6.525

3.  Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease.

Authors:  Jonathan Wang; Jacqueline J Masehi-Lano; Eun Ji Chung
Journal:  Biomater Sci       Date:  2017-07-25       Impact factor: 6.843

Review 4.  Improving kidney targeting: The influence of nanoparticle physicochemical properties on kidney interactions.

Authors:  Yi Huang; Jonathan Wang; Kairui Jiang; Eun Ji Chung
Journal:  J Control Release       Date:  2021-04-20       Impact factor: 11.467

5.  Identification of a Peptide from In vivo Bacteriophage Display with Homology to EGFL6: A Candidate Tumor Vasculature Ligand in Breast Cancer.

Authors:  Benjamin M Larimer; Susan L Deutscher
Journal:  J Mol Biomark Diagn       Date:  2014-05

6.  Transmissible gastroenteritis virus: identification of M protein-binding peptide ligands with antiviral and diagnostic potential.

Authors:  Hao Zou; Dante S Zarlenga; Karol Sestak; Siqingaowa Suo; Xiaofeng Ren
Journal:  Antiviral Res       Date:  2013-07-02       Impact factor: 5.970

Review 7.  Vascular Endothelial Cells: Heterogeneity and Targeting Approaches.

Authors:  Jan K Hennigs; Christiane Matuszcak; Martin Trepel; Jakob Körbelin
Journal:  Cells       Date:  2021-10-10       Impact factor: 6.600

Review 8.  The potential of RNA-based therapy for kidney diseases.

Authors:  Tjessa Bondue; Lambertus van den Heuvel; Elena Levtchenko; Roland Brock
Journal:  Pediatr Nephrol       Date:  2022-05-04       Impact factor: 3.651

Review 9.  Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles.

Authors:  Zhigang Ju; Wei Sun
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.